Institutional investors purchased a net $2.4 million shares of ENTA during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 39.16% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RA CAPITAL MANAGEMENT LLC Bought 1.5 Million shares of Enanta Pharmaceuticals In...
FIDELITY MANAGEMENT & RESEARCH C... Bought 779.4 Thousand shares of Enanta Pharmaceuticals In...